101 related articles for article (PubMed ID: 21966773)
1. [Influence of the high peak serum estradiol on the outcome of in vitro fertilization cycles].
Carmona-Ruiz IO; Galache-Vega P; Santos-Haliscak R; Díaz-Spíndola P; Batiza-Reséndiz VA; Hernández-Ayup S
Ginecol Obstet Mex; 2010 Oct; 78(10):553-8. PubMed ID: 21966773
[TBL] [Abstract][Full Text] [Related]
2. The effects of peak and mid-luteal estradiol levels on in vitro fertilization outcome.
Moraloğlu Ö; Tonguc EA; Özel M; Özakşit G; Var T; Sarikaya E
Arch Gynecol Obstet; 2012 Mar; 285(3):857-62. PubMed ID: 21938500
[TBL] [Abstract][Full Text] [Related]
3. Serum estradiol levels during controlled ovarian hyperstimulation influence the pregnancy outcome of in vitro fertilization in a concentration-dependent manner.
Joo BS; Park SH; An BM; Kim KS; Moon SE; Moon HS
Fertil Steril; 2010 Feb; 93(2):442-6. PubMed ID: 19394001
[TBL] [Abstract][Full Text] [Related]
4. High serum estradiol levels are not detrimental to in vitro fertilization outcome.
Wu CH; Kuo TC; Wu HH; Yeh GP; Tsai HD
Taiwan J Obstet Gynecol; 2007 Mar; 46(1):54-9. PubMed ID: 17389191
[TBL] [Abstract][Full Text] [Related]
5. A preliminary study on reduced dose (33 or 25 microg) gonadotropin-releasing hormone agonist long protocol for multifollicular ovarian stimulation in patients with high basal serum follicle-stimulating hormone levels undergoing in vitro fertilization-embryo transfer.
Ku SY; Choi YS; Jee BC; Suh CS; Choi YM; Kim JG; Moon SY; Kim SH
Gynecol Endocrinol; 2005 Oct; 21(4):227-31. PubMed ID: 16316845
[TBL] [Abstract][Full Text] [Related]
6. High estradiol levels and high oocyte yield are not detrimental to in vitro fertilization outcome.
Sharara FI; McClamrock HD
Fertil Steril; 1999 Sep; 72(3):401-5. PubMed ID: 10519607
[TBL] [Abstract][Full Text] [Related]
7. Effects of ovarian high response on implantation and pregnancy outcome during controlled ovarian hyperstimulation (with GnRH agonist and rFSH).
Chen QJ; Sun XX; Li L; Gao XH; Wu Y; Gemzell-Danielsson K; Cheng LN
Acta Obstet Gynecol Scand; 2007; 86(7):849-54. PubMed ID: 17611831
[TBL] [Abstract][Full Text] [Related]
8. A comparison of gonadotropin-releasing hormone (GnRH) antagonist and GnRH agonist flare protocols for poor responders undergoing in vitro fertilization.
Berin I; Stein DE; Keltz MD
Fertil Steril; 2010 Feb; 93(2):360-3. PubMed ID: 19131055
[TBL] [Abstract][Full Text] [Related]
9. Comparison of GnRH antagonists and flareup GnRH agonists in donor oocyte cycles.
Wei AY; Mijal KA; Christianson MS; Schouweiler CM; Lindheim SR
J Reprod Med; 2008 Mar; 53(3):147-50. PubMed ID: 18441715
[TBL] [Abstract][Full Text] [Related]
10. GnRH agonist (buserelin) or hCG for ovulation induction in GnRH antagonist IVF/ICSI cycles: a prospective randomized study.
Humaidan P; Bredkjaer HE; Bungum L; Bungum M; Grøndahl ML; Westergaard L; Andersen CY
Hum Reprod; 2005 May; 20(5):1213-20. PubMed ID: 15760966
[TBL] [Abstract][Full Text] [Related]
11. [Hormone profile and follicle development in ovarian stimulation treatment for in vitro fertilization. II. Prolactin, estradiol and progesterone profile].
Sudik R; Fliess FR; Kunkel S
Zentralbl Gynakol; 1989; 111(9):567-80. PubMed ID: 2500795
[TBL] [Abstract][Full Text] [Related]
12. Follicular phase serum levels of luteinizing hormone do not influence delivery rates in in vitro fertilization cycles down-regulated with a gonadotropin-releasing hormone agonist and stimulated with recombinant follicle-stimulating hormone.
Cabrera RA; Stadtmauer L; Mayer JF; Gibbons WE; Oehninger S
Fertil Steril; 2005 Jan; 83(1):42-8. PubMed ID: 15652885
[TBL] [Abstract][Full Text] [Related]
13. [Effect of desogestrel and ethinyl estradiol pretreatment in superovulation cycles with short protocol].
Zhao JZ; Lin XH; Huang XF; Lin JJ; Lin WQ; Ye BL
Zhonghua Fu Chan Ke Za Zhi; 2008 Feb; 43(2):102-5. PubMed ID: 18683747
[TBL] [Abstract][Full Text] [Related]
14. The serum follicle-stimulating hormone-to-luteinizing hormone ratio at the start of stimulation with gonadotropins after pituitary down-regulation is inversely correlated with a mature oocyte yield and can predict "low responders".
Ho JY; Guu HF; Yi YC; Chen MJ; Ho ES
Fertil Steril; 2005 Apr; 83(4):883-8. PubMed ID: 15820795
[TBL] [Abstract][Full Text] [Related]
15. Estradiol supplementation during the luteal phase of IVF-ICSI patients: a randomized, controlled trial.
Serna J; Cholquevilque JL; Cela V; Martínez-Salazar J; Requena A; Garcia-Velasco JA
Fertil Steril; 2008 Dec; 90(6):2190-5. PubMed ID: 18191847
[TBL] [Abstract][Full Text] [Related]
16. [Clinical outcome of patients with follicular development retardation by prolonged duration of gonadotropin administration for in vitro fertilization].
Chen SL; Sun L; Kong LH; Li L; Li J; Zhu L; Gao TM; Xing FQ
Zhonghua Fu Chan Ke Za Zhi; 2007 Aug; 42(8):526-9. PubMed ID: 17983490
[TBL] [Abstract][Full Text] [Related]
17. Serum antimüllerian hormone/müllerian-inhibiting substance appears to be a more discriminatory marker of assisted reproductive technology outcome than follicle-stimulating hormone, inhibin B, or estradiol.
Hazout A; Bouchard P; Seifer DB; Aussage P; Junca AM; Cohen-Bacrie P
Fertil Steril; 2004 Nov; 82(5):1323-9. PubMed ID: 15533354
[TBL] [Abstract][Full Text] [Related]
18. Elevated E2: oocyte ratio in women undergoing IVF and tubal ET. Correlation with a decrease in the implantation rate.
Yang JH; Chen HF; Lien YR; Chen SU; Ho HN; Yang YS
J Reprod Med; 2001 May; 46(5):434-8. PubMed ID: 11396368
[TBL] [Abstract][Full Text] [Related]
19. Comparison of luteal estradiol patch and gonadotropin-releasing hormone antagonist suppression protocol before gonadotropin stimulation versus microdose gonadotropin-releasing hormone agonist protocol for patients with a history of poor in vitro fertilization outcomes.
Weitzman VN; Engmann L; DiLuigi A; Maier D; Nulsen J; Benadiva C
Fertil Steril; 2009 Jul; 92(1):226-30. PubMed ID: 18675961
[TBL] [Abstract][Full Text] [Related]
20. Short coasting of 1 or 2 days by withholding both gonadotropins and gonadotropin-releasing hormone agonist prevents ovarian hyperstimulation syndrome without compromising the outcome.
Moon HS; Joo BS; Moon SE; Lee SK; Kim KS; Koo JS
Fertil Steril; 2008 Dec; 90(6):2172-8. PubMed ID: 18439601
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
